1. Academic Validation
  2. Serine ADP-ribosylation reversal by the hydrolase ARH3

Serine ADP-ribosylation reversal by the hydrolase ARH3

  • Elife. 2017 Jun 26;6:e28533. doi: 10.7554/eLife.28533.
Pietro Fontana 1 Juan José Bonfiglio 2 Luca Palazzo 1 Edward Bartlett 1 Ivan Matic 2 Ivan Ahel 1
Affiliations

Affiliations

  • 1 Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
  • 2 Max Planck Institute for Biology of Ageing, Cologne, Germany.
Abstract

ADP-ribosylation (ADPr) is a posttranslational modification (PTM) of proteins that controls many cellular processes, including DNA repair, transcription, chromatin regulation and mitosis. A number of proteins catalyse the transfer and hydrolysis of ADPr, and also specify how and when the modification is conjugated to the targets. We recently discovered a new form of ADPr that is attached to serine residues in target proteins (Ser-ADPr) and showed that this PTM is specifically made by PARP1/HPF1 and PARP2/HPF1 complexes. In this work, we found by quantitative proteomics that histone Ser-ADPr is reversible in cells during response to DNA damage. By screening for the hydrolase that is responsible for the reversal of Ser-ADPr, we identified ARH3/ADPRHL2 as capable of efficiently and specifically removing Ser-ADPr of histones and other proteins. We further showed that Ser-ADPr is a major PTM in cells after DNA damage and that this signalling is dependent on ARH3.

Keywords

ADP-ribose; ADP-ribosylation; ARH3; PARP; biochemistry; human; macrodomain.

Figures